Image (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 01)
Sitagliptin Tablet
Product Images NDC 70771-1791
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin (NDC 70771-1791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 02)
Not available*
Image (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 03)
25 mg Label (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 04)
50 mg Label (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 05)
Sitagliptin Tablets are a medication commonly used for the treatment of type 2 diabetes. Each film coated tablet contains 50 mg of Sitagliptin. The recommended dosage should be followed as per the prescribing information. It is important to store the tablets in the original container, protecting them from moisture. Once the bottle is opened, the tablets must be used within 3 months. The package is child resistant and should be kept out of reach of children. The medication guide should be dispensed to each patient, providing important information about the drug. For further information, the medication guide is available online at www.zydususa.com/medguides or you can call 1-877-993-8779. The tablets are manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India.*
100 mg Label (Dc9e1209 8ee7 4ddb Aadc 7057ae2a3d23 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
